LONDON – Researchers in the UK are planning the first of its kind to quickly gauge the effectiveness of multiple vaccines against Covid-19 by launching an infection of healthy volunteers with a tightly controlled dose of coronavirus in early 2021. The so-called humanitarian challenge plans target children aged 18 to …
Read More »
Pfizer Inc. P.F.E. -0.84% Said it may be ready to apply for emergency-use authorization of its Covid-19 vaccine by the end of November, believing that in late-stage human trials will yield positive efficacy and safety data, the first time it or any other leading Western vaccine developer This kind of …
Read More »
File – This September 2020 photo, provided by Johnson & Johnson, shows a single-dose COVID-19 vaccine being developed by the company. A.P. European stocks held lower on Tuesday, with traders losing momentum after halting key coronavirus trials waiting for earnings from some of the world’s leading banks. Stocks Europe 600 …
Read More »
The notion of herd immunity is at the center of discussion about global vaccination efforts and the next steps in fighting the Covid-19 epidemic and bringing the economy back on track. In order for the epidemic to stop, the coronavirus has to run out of susceptible hosts to become infected. …
Read More »
Capped vials of Oxford University’s COVID-19 vaccine candidate, who resumed trials after a break last week. Vincenzo Pinto / Agence France-Presse / Getty Images European stocks rallied on Monday, with US equity futures driven by news of vaccine hope, mergers and acquisitions. Stoxx Europe 600 Index SXXXP, -0.04% The best …
Read More »